About Indaptus Therapeutics, Inc. - Common Stock (INDP)
Indaptus Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with serious and life-threatening diseases. The company specializes in leveraging advanced technologies to create novel treatments that aim to harness the body's immune system and improve therapeutic outcomes. By advancing its pipeline of drug candidates, Indaptus Therapeutics seeks to address unmet medical needs and provide new hope for patients suffering from various forms of cancer and other challenging conditions. Read More
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's regular session. The market value of their outstanding shares is at $162.5 million. PDS Biotechnology (NASDAQ:PDSB)
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 34.0% to $1.26 during Thursday's regular session. The company's market cap stands at $125.2 million. BioVie (NASDAQ:BIVI) stock rose 30.85%
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
